Moderate to severe psoriasis treatment challenges through the era of biological drugs
An. bras. dermatol
;
92(5): 668-674, Sept.-Oct. 2017. tab
Artigo
em Inglês
| LILACS
| ID: biblio-887045
ABSTRACT
Abstract Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety and efficacy. There are also clinical forms of the disease and patient profiles for which is pending further scientific evidence for more sustained therapeutic interventions. The continuous and more detailed knowledge of psoriasis pathophysiology has allowed identifying new therapeutic targets, which is expected to help overcome the challenges of individualized psoriasis treatment.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Psoríase
Tipo de estudo:
Estudo prognóstico
Limite:
Humanos
Idioma:
Inglês
Revista:
An. bras. dermatol
Assunto da revista:
Dermatologia
Ano de publicação:
2017
Tipo de documento:
Artigo
País de afiliação:
Portugal
Instituição/País de afiliação:
São João Hospital Center/PT
Similares
MEDLINE
...
LILACS
LIS